title: Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease.
authors.affiliation: University of North Carolina at Chapel Hill School of Medicine, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Chapel Hill, NC 27599, USA.
authors.forename: C Michael
authors.initials: CM
authors.lastname: Osborne
authors.forename: Emily
authors.initials: E
authors.lastname: Hardisty
authors.forename: Patricia
authors.initials: P
authors.lastname: Devers
authors.forename: Kathleen
authors.initials: K
authors.lastname: Kaiser-Rogers
authors.forename: Melissa A
authors.initials: MA
authors.lastname: Hayden
authors.forename: William
authors.initials: W
authors.lastname: Goodnight
authors.forename: Neeta L
authors.initials: NL
authors.lastname: Vora
mesh_terms: D000328:Adult; D002869:Chromosome Aberrations; D002882:Chromosomes, Human, Pair 13 / Q000235:genetics; D002887:Chromosomes, Human, Pair 18 / Q000235:genetics; D005189:False Positive Reactions; D005260:Female; D005333:Fetus; D005820:Genetic Testing; D006801:Humans; D007231:Infant, Newborn; D007889:Leiomyoma / Q000473:pathology*; D008297:Male; D009362:Neoplasm Metastasis; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000473:pathology*; D011296:Prenatal Diagnosis; D014594:Uterine Neoplasms / Q000473:pathology*